Oxiconazole nitrate is a broad-spectrum topical imidazole antifungal agent. It is primarily used for the treatment of superficial dermatophyte infections (tinea) and cutaneous candidiasis. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, leading to increased membrane permeability and cell death. In the Indian context, it is a well-established, effective, and generally well-tolerated treatment for common fungal skin infections.
Adult: Apply a thin layer to the affected area and surrounding skin once daily (preferably in the evening). For tinea pedis, duration is typically 4 weeks. For tinea cruris/corporis, duration is typically 2 weeks.
Note: Wash and dry the affected area thoroughly before application. Apply a thin film and rub gently. Wash hands after application unless hands are being treated. Do not use in or near the eyes, nose, mouth, or vagina. For intertriginous areas, apply sparingly to avoid maceration.
Oxiconazole inhibits the fungal cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This inhibition blocks the conversion of lanosterol to ergosterol, an essential sterol component of the fungal cell membrane. Depletion of ergosterol and accumulation of toxic methylated sterol precursors disrupts membrane structure and function.
Pregnancy: Category B (US FDA). Animal studies have shown no risk, but no adequate and well-controlled studies in pregnant women. Use only if clearly needed and potential benefit justifies potential risk to the fetus. Topical application minimizes systemic exposure.
Driving: No effect on driving ability.
| Other topical medications (e.g., corticosteroids, retinoids, other antifungals) | Potential for physical/chemical incompatibility or increased local irritation. Sequential application with a gap is advised. | Moderate |
| Systemic Azole Antifungals (e.g., Ketoconazole, Fluconazole) | Theoretical risk of additive systemic effects, but highly unlikely with topical oxiconazole due to minimal absorption. | Low |